239 related articles for article (PubMed ID: 16192820)
1. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.
Posther KE; McCall LM; Blumencranz PW; Burak WE; Beitsch PD; Hansen NM; Morrow M; Wilke LG; Herndon JE; Hunt KK; Giuliano AE
Ann Surg; 2005 Oct; 242(4):593-9; discussion 599-602. PubMed ID: 16192820
[TBL] [Abstract][Full Text] [Related]
2. National practice patterns of sentinel lymph node dissection for breast carcinoma.
Lucci A; Kelemen PR; Miller C; Chardkoff L; Wilson L
J Am Coll Surg; 2001 Apr; 192(4):453-8. PubMed ID: 11294401
[TBL] [Abstract][Full Text] [Related]
3. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Giuliano AE; Hunt KK; Ballman KV; Beitsch PD; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; McCall LM; Morrow M
JAMA; 2011 Feb; 305(6):569-75. PubMed ID: 21304082
[TBL] [Abstract][Full Text] [Related]
4. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
[TBL] [Abstract][Full Text] [Related]
5. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
6. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
Giuliano AE; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Hunt KK; Morrow M; Ballman K
Ann Surg; 2010 Sep; 252(3):426-32; discussion 432-3. PubMed ID: 20739842
[TBL] [Abstract][Full Text] [Related]
7. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
Lucci A; McCall LM; Beitsch PD; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
J Clin Oncol; 2007 Aug; 25(24):3657-63. PubMed ID: 17485711
[TBL] [Abstract][Full Text] [Related]
8. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice.
Weiss A; Mittendorf EA; DeSnyder SM; Hwang RF; Bea V; Bedrosian I; Hoffman K; Adrade B; Sahin AA; Kuerer HM; Hunt KK; Caudle AS
Clin Breast Cancer; 2018 Aug; 18(4):276-281. PubMed ID: 29100726
[TBL] [Abstract][Full Text] [Related]
9. Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population.
Yi M; Kuerer HM; Mittendorf EA; Hwang RF; Caudle AS; Bedrosian I; Meric-Bernstam F; Wagner JL; Hunt KK
J Am Coll Surg; 2013 Jan; 216(1):105-13. PubMed ID: 23122536
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
[TBL] [Abstract][Full Text] [Related]
11. When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.
Olaya W; Wong J; Wong J; Morgan J; Kazanjian K; Lum S
Ann Surg Oncol; 2013 Feb; 20(2):627-32. PubMed ID: 22956069
[TBL] [Abstract][Full Text] [Related]
12. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.
Nason KS; Anderson BO; Byrd DR; Dunnwald LK; Eary JF; Mankoff DA; Livingston R; Schmidt RA; Jewell KD; Yeung RS; Moe RE
Cancer; 2000 Dec; 89(11):2187-94. PubMed ID: 11147588
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection.
Nayyar A; Strassle PD; Shen MR; Black JA; Gallagher KK; McGuire KP
Am J Surg; 2018 Oct; 216(4):706-712. PubMed ID: 30060915
[TBL] [Abstract][Full Text] [Related]
14. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
15. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.
Giuliano AE; Haigh PI; Brennan MB; Hansen NM; Kelley MC; Ye W; Glass EC; Turner RR
J Clin Oncol; 2000 Jul; 18(13):2553-9. PubMed ID: 10893286
[TBL] [Abstract][Full Text] [Related]
16. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer.
Haigh PI; Hansen NM; Qi K; Giuliano AE
Ann Surg Oncol; 2000; 7(1):21-7. PubMed ID: 10674444
[TBL] [Abstract][Full Text] [Related]
17. Improved axillary staging of breast cancer with sentinel lymphadenectomy.
Giuliano AE; Dale PS; Turner RR; Morton DL; Evans SW; Krasne DL
Ann Surg; 1995 Sep; 222(3):394-9; discussion 399-401. PubMed ID: 7677468
[TBL] [Abstract][Full Text] [Related]
18. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.
Wernicke AG; Goodman RL; Turner BC; Komarnicky LT; Curran WJ; Christos PJ; Khan I; Vandris K; Parashar B; Nori D; Chao KS
Breast Cancer Res Treat; 2011 Feb; 125(3):893-902. PubMed ID: 20853176
[TBL] [Abstract][Full Text] [Related]
19. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
